Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.85
- Piotroski Score 4.00
- Grade Overweight
- Symbol (FOLD)
- Company Amicus Therapeutics, Inc.
- Price $11.75
- Changes Percentage (3.71%)
- Change $0.42
- Day Low $11.21
- Day High $11.75
- Year High $14.57
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $14.50
- High Stock Price Target $19.00
- Low Stock Price Target $13.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.49
- Trailing P/E Ratio -20.51
- Forward P/E Ratio -20.51
- P/E Growth -20.51
- Net Income $-151,584,000
Income Statement
Quarterly
Annual
Latest News of FOLD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
How the Election Could Unfold: Four Scenarios
The 2024 election is uncertain due to challenges faced by both Democrats and Republicans....
By The New York Times | 13 hours ago -
Here's how Election Day 2024 might unfold around the US and in New...
Americans are voting for their 47th president and all House and Senate members, with close races expected. Swing states will determine the outcome. Polls suggest a tight race between Trump and Harris....
By New York Post | 13 hours ago -
Watch the AI robots that Jeff Bezos just invested in fold laundry and put eggs in a carton
Jeff Bezos has invested in Physical Intelligence, a startup developing AI software for versatile robots. The company aims to create robots that can perform various tasks such as folding laundry and cl...
By Business Insider | 1 day ago
